A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) reduce systolic blood pressure (SBP) and increase serum potassium concentration ([K(+)]). This indirect comparison investigated any differences in SBP-lowering and hyperkalemia risk between finerenone, a nonsteroidal MRA, and the steroidal MR...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Rajiv, Pitt, Bertram, Palmer, Biff F, Kovesdy, Csaba P, Burgess, Ellen, Filippatos, Gerasimos, Małyszko, Jolanta, Ruilope, Luis M, Rossignol, Patrick, Rossing, Peter, Pecoits-Filho, Roberto, Anker, Stefan D, Joseph, Amer, Lawatscheck, Robert, Wilson, Daniel, Gebel, Martin, Bakris, George L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972517/
https://www.ncbi.nlm.nih.gov/pubmed/36864892
http://dx.doi.org/10.1093/ckj/sfac234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972517/
https://www.ncbi.nlm.nih.gov/pubmed/36864892
http://dx.doi.org/10.1093/ckj/sfac234

Ejemplares similares